SKI Market

Indian Indices

Nifty

17,080.70 129.00
(0.76%)

Sensex

57,960.09 346.37
( 0.60%)

Bank Nifty

39,910.15 342.25
( 0.86%)

Nifty IT

28,011.30 308.55
( 1.11%)

Global Indices

Nasdaq

11,926.24 210.16
(1.79%)

Dow Jones

32,717.60 323.35
(1.00%)

Hang Seng

20,309.13 116.73
(0.58%)

Nikkei 225

27,782.93 -100.85
(-0.36%)

Forex

USD-INR

82.23 -0.09
(-0.10%)

EUR-INR

89.03 0.31
(0.35%)

GBP-INR

101.31 0.39
(0.38%)

JPY-INR

0.63 0.00
(0.20%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Colgate-Palmolive (India) Ltd

Industry : Personal Care - Multinational

BSE Code

ISIN Demat

Book Value()

500830

INE259A01022

60.7105066

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

COLPAL

38.34

40686.33

EPS(TTM)

Face Value()

Div & Yield %

39.02

2.67

Back

Bafna Pharmaceuticals standalone net profit declines 32.35% in the September 2022 quarter

Nov 11,2022

Net profit of Bafna Pharmaceuticals declined 32.35% to Rs 1.61 crore in the quarter ended September 2022 as against Rs 2.38 crore during the previous quarter ended September 2021. Sales declined 22.78% to Rs 21.96 crore in the quarter ended September 2022 as against Rs 28.44 crore during the previous quarter ended September 2021.

Particulars	Quarter Ended
	Sep. 2022	Sep. 2021	% Var.
Sales	21.96	28.44	-23
OPM %	11.57	20.04	-
PBDT	2.73	5.77	-53
PBT	1.61	4.35	-63
NP	1.61	2.38	-32

17,080.70 129.00 (0.76%)

57,960.09 346.37 ( 0.60%)

39,910.15 342.25 ( 0.86%)

28,011.30 308.55 ( 1.11%)

11,926.24 210.16 (1.79%)

32,717.60 323.35 (1.00%)

20,309.13 116.73 (0.58%)

27,782.93 -100.85 (-0.36%)

82.23 -0.09 (-0.10%)

89.03 0.31 (0.35%)

101.31 0.39 (0.38%)

0.63 0.00 (0.20%)